JP5747205B2 - 抗インフルエンザ剤 - Google Patents
抗インフルエンザ剤 Download PDFInfo
- Publication number
- JP5747205B2 JP5747205B2 JP2010053732A JP2010053732A JP5747205B2 JP 5747205 B2 JP5747205 B2 JP 5747205B2 JP 2010053732 A JP2010053732 A JP 2010053732A JP 2010053732 A JP2010053732 A JP 2010053732A JP 5747205 B2 JP5747205 B2 JP 5747205B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- influenza
- agaricus
- sample
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010022000 influenza Diseases 0.000 title claims description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 130
- 239000000284 extract Substances 0.000 claims description 97
- 235000013305 food Nutrition 0.000 claims description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- 239000003795 chemical substances by application Substances 0.000 claims description 29
- 241000196324 Embryophyta Species 0.000 claims description 27
- 238000011282 treatment Methods 0.000 claims description 21
- 244000281247 Ribes rubrum Species 0.000 claims description 15
- 235000002355 Ribes spicatum Nutrition 0.000 claims description 14
- 235000001466 Ribes nigrum Nutrition 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 12
- 240000001717 Vaccinium macrocarpon Species 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 10
- 241001327634 Agaricus blazei Species 0.000 claims description 9
- 239000004480 active ingredient Substances 0.000 claims description 9
- 241001312569 Ribes nigrum Species 0.000 claims description 8
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims description 8
- 235000004634 cranberry Nutrition 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- 235000001537 Ribes X gardonianum Nutrition 0.000 claims description 7
- 235000001535 Ribes X utile Nutrition 0.000 claims description 7
- 235000016919 Ribes petraeum Nutrition 0.000 claims description 7
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims description 7
- 244000078534 Vaccinium myrtillus Species 0.000 claims description 5
- 244000301850 Cupressus sempervirens Species 0.000 claims description 4
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 4
- 241000894007 species Species 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 244000133098 Echinacea angustifolia Species 0.000 claims 1
- 235000014134 echinacea Nutrition 0.000 claims 1
- 241000222518 Agaricus Species 0.000 description 56
- 235000013399 edible fruits Nutrition 0.000 description 27
- 241000712461 unidentified influenza virus Species 0.000 description 26
- 238000004519 manufacturing process Methods 0.000 description 21
- 230000000694 effects Effects 0.000 description 20
- 208000015181 infectious disease Diseases 0.000 description 19
- 239000000047 product Substances 0.000 description 19
- 239000000203 mixture Substances 0.000 description 15
- 238000012360 testing method Methods 0.000 description 14
- 238000000034 method Methods 0.000 description 13
- 239000002904 solvent Substances 0.000 description 13
- 230000009385 viral infection Effects 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 241000700605 Viruses Species 0.000 description 9
- 235000013361 beverage Nutrition 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 235000016911 Ribes sativum Nutrition 0.000 description 7
- 235000016897 Ribes triste Nutrition 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 210000004698 lymphocyte Anatomy 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 241000712431 Influenza A virus Species 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 240000001890 Ribes hudsonianum Species 0.000 description 4
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 235000011511 Diospyros Nutrition 0.000 description 3
- 244000236655 Diospyros kaki Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 244000077923 Vaccinium vitis idaea Species 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 230000002301 combined effect Effects 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 238000005342 ion exchange Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 235000012149 noodles Nutrition 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000002911 sialidase inhibitor Substances 0.000 description 3
- 239000007901 soft capsule Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 2
- 244000070268 Agaricus arvensis Species 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000003322 Coinfection Diseases 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 244000294411 Mirabilis expansa Species 0.000 description 2
- 235000015429 Mirabilis expansa Nutrition 0.000 description 2
- 235000016357 Mirtillo rosso Nutrition 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 241000736767 Vaccinium Species 0.000 description 2
- 235000012511 Vaccinium Nutrition 0.000 description 2
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 235000012970 cakes Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 229940042406 direct acting antivirals neuraminidase inhibitors Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 235000013536 miso Nutrition 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- 235000015067 sauces Nutrition 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- -1 sucrose fatty acid esters Chemical class 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 229940104230 thymidine Drugs 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- 230000003313 weakening effect Effects 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000008318 Agaricus arvensis Nutrition 0.000 description 1
- 244000251953 Agaricus brunnescens Species 0.000 description 1
- 240000007440 Agaricus campestris Species 0.000 description 1
- 240000007068 Agaricus silvaticus Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241001500351 Influenzavirus A Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000005135 Micromeria juliana Nutrition 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 102000005348 Neuraminidase Human genes 0.000 description 1
- 108010006232 Neuraminidase Proteins 0.000 description 1
- 229940123424 Neuraminidase inhibitor Drugs 0.000 description 1
- 241000712464 Orthomyxoviridae Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 240000008819 Ribes americanum Species 0.000 description 1
- 241000305775 Rynchops niger Species 0.000 description 1
- 240000002114 Satureja hortensis Species 0.000 description 1
- 235000007315 Satureja hortensis Nutrition 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 235000005480 Vaccinium bracteatum Nutrition 0.000 description 1
- 244000287839 Vaccinium bracteatum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 244000291414 Vaccinium oxycoccus Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000035584 blastogenesis Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000021019 cranberries Nutrition 0.000 description 1
- 235000020237 cranberry extract Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000007907 direct compression Methods 0.000 description 1
- 235000015071 dressings Nutrition 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013332 fish product Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000019674 grape juice Nutrition 0.000 description 1
- 235000015220 hamburgers Nutrition 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000002035 hexane extract Substances 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- 208000037798 influenza B Diseases 0.000 description 1
- 229960003971 influenza vaccine Drugs 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000020888 liquid diet Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 108010086652 phytohemagglutinin-P Proteins 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000019814 powdered cellulose Nutrition 0.000 description 1
- 229920003124 powdered cellulose Polymers 0.000 description 1
- 235000020991 processed meat Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Landscapes
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
Description
アガリクス ブラゼイ ムリルの乾燥子実体を約0.7cm角サイズに粗砕したもの300gをステンレス製耐圧釜に仕込み、イオン交換水3Lを添加し、常圧下、90℃で3時間抽出処理した後、減圧濾過して残渣を分離し第1抽出液を採取した。次いで、前記残渣にイオン交換水2.5Lを加えて同様に処理して第2抽出液を採取した。両抽出液を合わせて減圧濃縮及び凍結乾燥処理し、アガリクス茸抽出物(試料1)40.5gを得た。
製造例1において、常圧下を1.3気圧の加圧下に置き換えて同様に処理してアガリクス茸抽出物(試料2)88.0gを得た。
製造例2で得た試料2の一部50gにエタノール濃度が65%の含水エタノール400mLを加え、常圧下で一旦溶解後30℃にて1時間静置し、生じた沈殿物を遠心分離して前記含水エタノールに可溶の画分と不溶の画分に分別した。含水エタノール可溶画分は、減圧濃縮及び凍結乾燥して前記含水エタノールに可溶のアガリクス茸抽出物(試料3)17.4gを得た。又、含水エタノール不溶画分(沈殿物)は、加水後、減圧濃縮でアルコールを除去し凍結乾燥して前記含水エタノールに不溶のアガリクス茸抽出物(試料4)32.1gを得た。
アガリクス ブラゼイ ムリルの乾燥菌糸体300gをステンレス製耐圧釜に仕込み、イオン交換水3Lを添加し、常圧下、90℃で3時間抽出処理した後、精密濾過して残渣を分離し第1抽出液を採取した。次いで、前記残渣にイオン交換水2.5Lを加えて同様に処理して第2抽出液を採取した。両抽出液を合わせて減圧濃縮及び凍結乾燥し、アガリクス茸抽出物(試料5)143.2gを得た。
製造例4で得た試料5の一部50gにエタノール濃度が40%の含水エタノール400mLを加え、常圧下で一旦溶解後30℃にて1時間静置し、生じた沈殿物を遠心分離して採取した。この沈殿物に加水した後、減圧濃縮でアルコールを除去し更に乾燥処理して前記含水エタノールに不溶のアガリクス茸抽出物(試料6)30.6gを得た。
マッシュルームの生の子実体500gを約0.5mm角サイズに細断してステンレス製耐圧釜に仕込み、イオン交換水10Lを加え、常圧下、70℃で1時間抽出処理した後、減圧濾過して残渣を分離した抽出液を得た。次いで、この抽出液に最終エタノール濃度が50%になるようにエタノールを添加してゆるやかに攪拌し、常圧下、30℃にて5時間静置後、生じた沈殿物を遠心分離して採取した。更に、この沈殿物に加水、減圧濃縮及び凍結乾燥して、前記エタノール不溶分からなるアガリクス茸抽出物(試料7)40.5gを得た。
カシスの果実部の圧搾液1Lにエタノール濃度が70%の含水エタノール10Lを加え、常圧下、40〜50℃で30分間抽出処理し、残渣除去、濃縮及び乾燥処理してカシス抽出物(試料8)7.3gを得た。
クランベリーの果実部の乾燥物100gにエタノール濃度が70%の含水エタノール1Lを加え加え、50〜60℃で2時間抽出処理し、残渣除去、濃縮及び乾燥処理してクランベリー抽出物(試料9)21.6gを得た。
コケモモの果実及び葉の乾燥混合物100gにエタノール濃度が90%の含水エタノール1Lを加え加え、50〜60℃で2時間抽出処理し、残渣除去、濃縮及び乾燥処理してコケモモ抽出物(試料10)15.0gを得た。
アガリクス ブラゼイ ムリルの乾燥子実体を約0.7cm角サイズに粗砕したもの300gをステンレス製耐圧釜に仕込み、ヘキサン3Lを添加し、常温常圧下で1時間抽出処理後、減圧濾過して抽出液と残渣に分離した。抽出液を脱溶媒及び乾燥処理してヘキサン抽出物(比較試料1)を得た。この抽出物の成分は遊離脂肪酸、エルゴステロール等の遊離ステロール及びその配糖体、リン脂質、セラミド等の脂質類がほとんどを占め、遊離脂肪酸はリノール酸が主成分であった。
本試験において、インフルエンザウィルス株はインフルエンザウィルスA/NWS/33(H1N1)を用いた。又、細胞はMadin−Darby canine kidney(MDCK)細胞を、細胞の培養には2%fetal bovine serum(FBS)含有Eagle’s minimal essential medium(MEM)培地を用いた。
48穴プレートにMDCK細胞を播き、2%FBS含有MEM培地で培養した後、同培地に溶解した試料とウィルス液(0.2PFU/Cell)を添加して室温で1時間放置した後、前記培養培地を除去し、さらに前記培地で3回洗浄して細胞に感染していないウィルスを除去した後、前記培地に溶解した試料を再度添加して37℃、5%CO2条件下で24時間培養した。培養終了後、−80℃の冷凍庫へ移し、細胞を死滅させた後、ウィルス量をプラークアッセイ法で測定した。片対数グラフ上で50%ウィルス増殖阻害濃度(IC50)を求めた。この結果を表1に示す。同表において、IC50の値が小さいものほど、インフルエンザウィルスの感染を阻害している効果が高いことを示す。
BALB/cマウス(雌、6週齢)に試料を2週間連続経口投与した後、A型インフルエンザウィルス(H1/N1株)を7.5(log)TCID50にて経鼻感染させた(一次感染)。該感染3日後、血液を採取してリンパ球の幼弱化試験を行った。更に、マウスを屠殺して脾臓を摘出し、該脾臓から調製したリンパ球のNK活性を測定した。
リンパ球幼若化試験は、回収した末梢血リンパ球を3H−Thymidine存在下でフィトヘマグルチニンPによる抗原刺激を行い96時間培養した後の3H−Thymidineの取込量を液体シンチレーションカウンターにて測定した。生理食塩水投与群を100として増減の割合を求めた。又、NK活性は、マウスの脾臓より調製したリンパ球を、51Crを標識したYac−1細胞を標的細胞として混合培養を行い、放出された51Cr量を液体シンチレーションカウンターにて測定し、次式によりNK活性を求めた。
%Lysis=100×((検体の51Cr遊離値(cpm)−自然51Cr遊離値(cpm))/(最大51Cr遊離値(cpm)−自然51Cr遊離値(cpm))
本試験の結果を表2にまとめた。
BALB/cマウス(雌、6週齢)に試料を2週間連続経口投与した後、A型インフルエンザウィルス(H1/N1株)を7.5(log)TCID50にて経鼻感染させた(一次感染)。インフルエンザウィルス感染後も引き続き試料の経口投与を試験期間中継続して行った。感染3週間後、9.5(log)TCID50にて再度前記インフルエンザウィルスを経鼻感染させた(二次感染)。二回目の感染後のマウスの生存数を観察した。試料は全て100mg/kgで経口投与した。本試験の結果を表3にまとめた。
製造例3に記載の方法で調製したアガリクス茸の子実体の熱水抽出物の含水エタノール沈殿画分(試料4):170部、ミツロウ:30部及びコーン油:50部を約50℃に加熱混合して均質にした後、カプセル充填機に供して、常法により1粒あたり内容量が300mgのゼラチン被覆ソフトカプセル製剤を試作した。また、前記試料4を製造例1の方法で調製したアガリクス茸の熱水抽出物(試料1)に置き換えることを除き同様に処理してソフトカプセル製剤を試作した。これらのカプセル製剤は経口摂取できる栄養補助食品又は医薬品として利用できる。
試作例1において、試料4:170部を試料4:100部及び製造例8の方法で調製したクランベリーの含水エタノール抽出物(試料9):70部の混合物に置きかえて同様に処理して栄養補助食品を試作した。
試作例1において、試料4:170部を製造例2の方法で調製したアガリクス茸の加圧熱水抽出物(試料2):130部及び製造例7の方法で調製したカシスの抽出物(試料8):40部の混合物に置きかえて同様に処理して栄養補助食品を試作した。
試料2:100部、製造例5の方法で調製したアガリクス茸の菌糸体抽出物のエタノール沈殿画分(試料6):30部、化工デンプン(松谷化学工業(株)製、商品名:「パインフロー」):70部、リン酸三カルシウム(米山化学工業(株)製):85部、及びセルロース35部を混合機に仕込み、10分間攪拌混合した。この混合物を直打式打錠機に供して直径7mm、高さ4mm、重量150mg/個の素錠を作成し、ついでコーティング機でシェラック被膜を形成させて錠剤形状の経口摂取用組成物を試作した。
市販のグレープジュース1000部に製造例6の方法で調製したアガリクス茸の子実体抽出物のエタノール不溶画分(試料7):10部及び試料9:3部を加えて十分に混合し均質なグレープ風味飲料を試作した。これは冷蔵庫で1週間保存しても外観及び風味に異状及び違和感は認められなかった。
Claims (4)
- アガリクス ブラゼイ ムリル(Agaricus blazei Murill)の子実体を80℃以上の熱水で30分〜5時間抽出処理して得た熱水抽出物を、さらにエタノール濃度が40%以上かつ70%以下のエタノール水溶液を用いて抽出処理して得られる、該エタノール水溶液に不溶の成分を有効成分として含有してなることを特徴とする抗インフルエンザ剤(但し、エキナセアとの併用は除く。)。
- スグリ属及びスノキ属からなる群から選択される1種又は2種の属に属する植物の乾燥粉末及び/又は抽出物を併用するものである請求項1に記載の抗インフルエンザ剤。
- スグリ属に属する植物がカシスであり、スノキ属に属する植物がクランベリー又はコケモモである請求項2に記載の抗インフルエンザ剤。
- 請求項1〜3のいずれか1項に記載の抗インフルエンザ剤を配合してなることを特徴とする医薬品、飼料又はペットフード。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010053732A JP5747205B2 (ja) | 2010-02-19 | 2010-02-19 | 抗インフルエンザ剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010053732A JP5747205B2 (ja) | 2010-02-19 | 2010-02-19 | 抗インフルエンザ剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011168572A JP2011168572A (ja) | 2011-09-01 |
JP5747205B2 true JP5747205B2 (ja) | 2015-07-08 |
Family
ID=44683069
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010053732A Active JP5747205B2 (ja) | 2010-02-19 | 2010-02-19 | 抗インフルエンザ剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5747205B2 (ja) |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61165334A (ja) * | 1984-08-03 | 1986-07-26 | メデイサ−チ、エス、ア− | ウイルスの感染活性の抑制方法および組成物 |
JPH10139670A (ja) * | 1996-11-11 | 1998-05-26 | Terukuni Yakida | インターロイキン12誘導物質及び医薬組成物 |
WO1999044635A1 (en) * | 1998-03-05 | 1999-09-10 | The Medical College Of Ohio | Enhancement of immunity by intranasal inoculation of il-12 |
US7306815B2 (en) * | 2000-08-31 | 2007-12-11 | Phenolics, Llc | Compositions enriched in phenolic compounds and methods for producing the same |
JP2003183176A (ja) * | 2001-10-09 | 2003-07-03 | Wellness Movement:Kk | 免疫賦活組成物 |
JP4165690B2 (ja) * | 2002-05-13 | 2008-10-15 | 株式会社応微研 | インターロイキン12産生促進組成物の製造方法 |
JP4826696B2 (ja) * | 2003-04-07 | 2011-11-30 | ビーエイチエヌ株式会社 | 血管新生阻害剤 |
NO20044581L (no) * | 2004-01-12 | 2005-07-13 | Geir Hetland | Anvendelse av soppen Agaricus blazei Murill ved fremstilling av medikamenter til bekjempelse av infeksjoner og allergier |
JP2007159511A (ja) * | 2005-12-15 | 2007-06-28 | Atsushi Umemura | 健康食品及び健康茶 |
JP5216957B2 (ja) * | 2006-06-06 | 2013-06-19 | ビーエイチエヌ株式会社 | 変異原性抑制剤 |
KR20110005796A (ko) * | 2008-03-18 | 2011-01-19 | 가부시키가이샤 아미노 압 가가쿠 | 경장영양제 |
JP2009269861A (ja) * | 2008-05-08 | 2009-11-19 | Tama Seikagaku Kk | カシス果実由来のウィルス感染予防・治療剤 |
-
2010
- 2010-02-19 JP JP2010053732A patent/JP5747205B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2011168572A (ja) | 2011-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101982326B1 (ko) | 근육 질환 예방, 개선 또는 치료용 또는 근 기능 개선용 조성물 | |
JP2012236826A (ja) | 美肌促進剤及びその利用 | |
CN114502184A (zh) | 防治冠状病毒感染的包括杜英萃取物的药物和食品组合物 | |
JP5685752B2 (ja) | 血流促進改善剤 | |
JP5594819B2 (ja) | 脂質代謝改善用組成物 | |
JP6751709B2 (ja) | 筋肉細胞におけるエネルギー代謝活性化剤 | |
TWI239245B (en) | Medical composition for oral administration or intravenous administration for a disease requiring enhancement of nerve growth factor production for treatment or prevention | |
KR101534616B1 (ko) | 낙지다리 추출물을 유효성분으로 포함하는 항인플루엔자용 조성물 | |
KR101045031B1 (ko) | 꾸지뽕나무 열매 추출물을 함유하는 면역기능 강화용 조성물 | |
JP2008163002A (ja) | 肥満予防改善剤 | |
KR101828562B1 (ko) | 귤나무속 열매 발효물을 유효성분으로 포함하는 항바이러스용 조성물 | |
KR101039110B1 (ko) | 닥나무 물 추출물을 함유하는 면역기능 강화용 조성물 | |
JP2011173857A (ja) | コウゾ抽出物を含む免疫機能強化用組成物 | |
KR101443510B1 (ko) | 치커리 추출물을 유효성분으로 함유하는 인플루엔자 바이러스 감염 질환의 예방 또는 치료용 약학적 조성물 및 이의 제조방법 | |
JP2017193497A (ja) | 筋肉増強剤 | |
KR101331148B1 (ko) | 유동 추출물 또는 이의 분획물을 유효성분으로 함유하는 항바이러스용 조성물 | |
JP2008163003A (ja) | 脂肪吸収阻害剤 | |
WO2009069887A1 (en) | A pharmaceutical composition comprising glabridin or glabridin derivatives for suppression of dendritic cell maturation | |
JP5747205B2 (ja) | 抗インフルエンザ剤 | |
JP2008163004A (ja) | 脂肪蓄積抑制剤 | |
CN106132426B (zh) | 包含枳实提取物作为有效成分的抗流行性感冒病毒组合物 | |
KR20140106198A (ko) | 귤나무속 열매 발효물을 유효성분으로 포함하는 항바이러스용 조성물 | |
JP6541047B1 (ja) | 経口組成物 | |
JP5192215B2 (ja) | 免疫賦活組成物 | |
JP2010180141A (ja) | 抗アレルギー組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20121119 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140218 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140421 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140805 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20141006 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150324 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150331 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5747205 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S802 | Written request for registration of partial abandonment of right |
Free format text: JAPANESE INTERMEDIATE CODE: R311802 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |